Clinicians and researchers

• Sameh Osama

  Molecular detection of Staphylococcus aureus.

  I'm doing a research study on different mol. biology techniques that can be used for the detection of Staph. aureus in patient samples as a Diagnostic tool with a confirmative analysis approaches.I'm doing a research study on different mol. biology techniques that can be used for the detection of Staph. aureus in patient samples as a Diagnostic tool with a confirmative analysis approaches. Can anyone suggest names of techniques?

  Recent replies ⋅ Show All (1)

  • 
    Carlos Orozco Castaño replied

    hi, we do that in our lab by a real time PCR GeneXpert® if the use will be implemented for diagnostic i recomend this system, is very quick ( 50´). on the other hand is expensive. but reliable.

    Mar 26, 2012
• Aneek Das Bhowmik

  The new DRD4 (exon 3 VNTR) haplotype variation I have found in Indian MR population has been published recently in Genbank (JN383466)...

  http://www.ncbi.nlm.nih.gov/nuccore/JN383466

  Recent replies ⋅ Show All (1)

  • 
    Denis Solomons replied

    Tay - Sacks is caused by a recessive allele , ann allele that hides its terrible effects when it occurs with the normal allele ( in so-called carriers. ) !

    Mar 22, 2012
• Maninder Kaur

  How does miR-92b regulate Fragile X syndrome?

  miR-92b has 2 categories: miR-92-1 and miR-92-2. The location of miR-92-2 on the chromosome is Xq26.2 and the disease is caused on Xq27.3 location. Is there is any relationship of miR-92-2 and thismiR-92b has 2 categories: miR-92-1 and miR-92-2. The location of miR-92-2 on the chromosome is Xq26.2 and the disease is caused on Xq27.3 location. Is there is any relationship of miR-92-2 and this site? The FRAXA site is located Xq27.3 and is implicated in Fragile X syndrome. Can you recommend any good manuscripts on this topic?
• Maryam Pirhoushiaran

  epigenetics

  HI EVERYONE Dynamic mutation and their effect on the three nucleotide expansiion diseases is one of my faviorate area research. If you like we can discuss about it ;) i realy like to discuss aboutHI EVERYONE Dynamic mutation and their effect on the three nucleotide expansiion diseases is one of my faviorate area research. If you like we can discuss about it ;) i realy like to discuss about the gene therapy for human genetic diseases with epigenetic basis, like Fragile X or Huntington.@)-------

  Recent replies ⋅ Show All (3)

  • 
    Sham Prasad replied

    How do you think that epigenetics can be used to treat cancer

    Sep 9, 2011
• Emmilia Tan

  Mutations and polymorphisms

  I'm doing research on SCN1A gene that associated with generalized epilepsy with febrile seizure plus (GEFS+) . SCN1A gene (26exons). the total case for this study is 40 GEFS+ patients and 60 healthyI'm doing research on SCN1A gene that associated with generalized epilepsy with febrile seizure plus (GEFS+) . SCN1A gene (26exons). the total case for this study is 40 GEFS+ patients and 60 healthy control. after mutation screening: 1. first patient had missense mutation in exon 9 ( cag-ctg) and another one is in intron 7 IVS7+21 t>c , it doesn't effect rna splicing (already published elsewhere). is it possible? 2. second patient also had missense mutation in exon 26 (cat-cgt) and silent polymorphism in exon 9 (gta-gtg), this also published already elsewhere. is it possible?

  Recent replies ⋅ Show All (5)

  • 
    Aga Syed Sameer replied

    I am confused about what are u asking? Are u asking about your results in comparison to other studies. or aboutthe patients who have the mutations/polymorphisms. The results can be same as revealedI am confused about what are u asking? Are u asking about your results in comparison to other studies. or aboutthe patients who have the mutations/polymorphisms. The results can be same as revealed in other studies ..

    Jun 18, 2011
• Alka Venkatesh Ekbote

  Is anyone studying the cytogenetics for the cockayne or xeroderma pigmentosa?

  Recent replies ⋅ Show All (4)

  • 
    Alka Venkatesh Ekbote replied

    Thanks I have already written to Dr Helene, and their response was forthcoming . They are accepting the samples for both Xeroderma and Cockayne syndrome. If it helps anyone pls note.

    Jun 14, 2011
• Frederick Christopher Chullai

  Any suggested methods for altering the mutation in Duchenne Muscular Dystrophy?

  I would like to know if any methods in progress for altering the genetic mutation in chromosome Xp21.1 that leads to Duchenne Muscular Dystrophy.

  Recent replies ⋅ Show All (1)

  • 
    Anton Kiselev replied

    http://www.humgen.nl/lab-aartsma-rus/

    Dec 1, 2010